2017
Radiation Oncology Considerations in the Management of Mutation Carriers with Breast Cancer
Moran M. Radiation Oncology Considerations in the Management of Mutation Carriers with Breast Cancer. 2017, 151-170. DOI: 10.1007/978-3-319-59198-8_9.Peer-Reviewed Original ResearchBreast cancerMutation carriersRadiation therapyLocal-regional managementPost-mastectomy settingBreast conservation therapyBRCA mutation carriersTreatment management decisionsBRCA mutation statusHereditary breast cancerBreast conservationTNBC patientsConservation therapyBRCA carriersFamily historyMutation statusRadiation therapy deliveryTreatment conceptGenetic testingBRCA genesCancerTherapyStrong associationTherapy deliveryPresent guidelines
2009
Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups
Haffty BG, Choi DH, Goyal S, Silber A, Ranieri K, Matloff E, Lee MH, Nissenblatt M, Toppmeyer D, Moran MS. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Annals Of Oncology 2009, 20: 1653-1659. PMID: 19491284, DOI: 10.1093/annonc/mdp051.Peer-Reviewed Original ResearchConceptsBreast cancerSecondary malignanciesAge of onsetFamily historyBRCA1/2 mutationsYoung womenBRCA1/2 mutation statusBreast cancer diagnosisEligible womenSecond cancersInitial diagnosisBRCA1/2 statusMutation statusBRCA1/2 genesYounger ageKorean womenCancerMalignancyUncertain significanceCancer diagnosisCaucasiansWomenDiverse racial groupsFrequent mutationsSignificant differences